Full Text
PHM7 COST SIMULATION OF NOVOSEVEN VERSUS FEIBAAND ITT-F8 FOR PRIMARY PROPHYLAXIS TREATMENT OF HAEMOPHILIA A/B PATIENTS WITH INHIBITORS

Abstract

Authors

JH Weatherall

Back to Volume 10, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×